Nomegestrol acetate for symptomatic endometriosis and meningioma risk: understandable statistics for decision-making

Paolo Vercellini, Giovanna Esposito, Claudia Santucci, Fabio Parazzini, Parazzini F, Carlo La Vecchia, La Vecchia C
European journal of obstetrics, gynecology, and reproductive biology · 2023 · vol. 286 , pp. 149–150 · doi:10.1016/j.ejogrb.2023.05.002 · PMID:37183159 · W4372342889
letter OA: green CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This paper provides statistics on the use of nomegestrol acetate for endometriosis to help researchers understand its potential association with meningioma risk.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (7)

Source provenance

europepmc
last seen: 2026-08-18T06:10:16.649438+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-08-18T06:09:32.484041+00:00
License: CC0 · commercial use OK